Focal changes in ARMS included a gain of 12q13 and 13q14, containing MYO1A, STAT6, and FOXO1 genes, while the ERMS group had a gain of 12q15, containing both the FRS2 and MDM2 genes. Here, FRS2 is linked to embryonal rhabdomyosarcoma.